Inspire Medical Systems, Inc. (NYSE:INSP) Stock Has Consensus Price Target of $66.50

Inspire Medical Systems, Inc. (NYSE:INSP) has earned a consensus rating of “Hold” from the nineteen ratings firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $67.44.

Several research analysts have weighed in on INSP shares. Robert W. Baird increased their price target on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a “neutral” rating in a report on Tuesday, August 4th. JPMorgan Chase & Co. boosted their price objective on Inspire Medical Systems from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Weiss Ratings raised Inspire Medical Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, September 22nd. Royal Bank Of Canada increased their target price on Inspire Medical Systems from $60.00 to $75.00 and gave the stock a “sector perform” rating in a research note on Thursday. Finally, Oppenheimer raised Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 price target for the company in a report on Tuesday, August 4th.

Insider Buying and Selling

In related news, insider Jason Kelly sold 963 shares of the firm’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the transaction, the insider directly owned 18,985 shares of the company’s stock, valued at approximately $1,130,556.75. This trade represents a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Inspire Medical Systems

Large investors have recently modified their holdings of the stock. Envestnet Portfolio Solutions Inc. acquired a new position in Inspire Medical Systems in the second quarter valued at about $296,000. WINTON GROUP Ltd grew its stake in Inspire Medical Systems by 790.8% during the second quarter. WINTON GROUP Ltd now owns 37,412 shares of the company’s stock worth $1,669,000 after buying an additional 33,212 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Inspire Medical Systems during the second quarter worth about $131,000. Allworth Financial LP increased its holdings in Inspire Medical Systems by 275.7% in the 2nd quarter. Allworth Financial LP now owns 1,980 shares of the company’s stock valued at $88,000 after buying an additional 1,453 shares during the period. Finally, Nykredit A S bought a new position in Inspire Medical Systems in the 2nd quarter valued at about $78,000. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Price Performance

INSP stock opened at $70.77 on Thursday. Inspire Medical Systems has a one year low of $38.91 and a one year high of $147.03. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 15.32, a price-to-earnings-growth ratio of 5.29 and a beta of 0.73. The company has a fifty day moving average price of $63.88 and a two-hundred day moving average price of $53.80.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.38. The company had revenue of $200.58 million for the quarter, compared to analyst estimates of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company’s revenue was down 7.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Research analysts anticipate that Inspire Medical Systems will post 1.24 EPS for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead.